Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic disease.
Karolina GenteManuel FeisstDorothea MarxKarel D KlikaPetros ChristopoulosJürgen GrafJulia WillThomas LuftJessica C HasselCarsten Müller-TidowRui A CarvalhoHanns-Martin LorenzM Margarida Souto-CarneiroPublished in: Annals of the rheumatic diseases (2024)
This new set of metabolic markers reliably predicts the presence of cancer in arthritis or PN patients with high sensitivity and specificity and has the potential to facilitate a rapid and correct diagnosis of malignancy.